(Q35744848)

10 August 2017

title

Antiviral activity of the EB peptide against zoonotic poxviruses (English)

1 reference

10 August 2017

0 references

3

Peter B Jahrling

1 reference

10 August 2017

4

Joseph E Blaney

1 reference

10 August 2017

Sharon E Altmann

1

1 reference

10 August 2017

Curtis R Brandt

series ordinal

2

1 reference

10 August 2017

publication date

6 January 2012

1 reference

10 August 2017

1 reference

10 August 2017

volume

9

1 reference

10 August 2017

page(s)

6

1 reference

Creative Commons Attribution 2.0 Generic

10 August 2017

copyright license

start time

6 January 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Identification of the minimal active sequence of an anti-influenza virus peptide

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3275487

Major increase in human monkeypox incidence 30 years after smallpox vaccination campaigns cease in the Democratic Republic of Congo

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3275487

The virucidal EB peptide protects host cells from herpes simplex virus type 1 infection in the presence of serum albumin and aggregates proteins in a detergent-like manner

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3275487

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3275487

Characterization of a newly identified 35-amino-acid component of the vaccinia virus entry/fusion complex conserved in all chordopoxviruses

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3275487

The vaccinia virus gene I2L encodes a membrane protein with an essential role in virion entry

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3275487

Vaccinia virus l1 protein is required for cell entry and membrane fusion

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3275487

Inhibition of influenza virus infection by a novel antiviral peptide that targets viral attachment to cells

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3275487

Vaccinia virus G9 protein is an essential component of the poxvirus entry-fusion complex

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3275487

Vaccinia virus F9 virion membrane protein is required for entry but not virus assembly, in contrast to the related L1 protein

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3275487

The envelope G3L protein is essential for entry of vaccinia virus into host cells

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3275487

Corneal toxicity of cell-penetrating peptides that inhibit Herpes simplex virus entry

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3275487

Poxvirus multiprotein entry-fusion complex

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3275487

Vaccinia virus A21 virion membrane protein is required for cell entry and fusion

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3275487

Vaccinia virus H2 protein is an essential component of a complex involved in virus entry and cell-cell fusion

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3275487

Studying the binding and entry of the intracellular and extracellular enveloped forms of vaccinia virus

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3275487

Modified FGF4 signal peptide inhibits entry of herpes simplex virus type 1.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3275487

Vaccinia virus envelope D8L protein binds to cell surface chondroitin sulfate and mediates the adsorption of intracellular mature virions to cells

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3275487

A27L protein mediates vaccinia virus interaction with cell surface heparan sulfate

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3275487

Inhibition of nuclear translocation of transcription factor NF-kappa B by a synthetic peptide containing a cell membrane-permeable motif and nuclear localization sequence

27 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-9-6

Inhibition of Vaccinia virus entry by a broad spectrum antiviral peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-9-6

Vaccinia virus entry into cells is dependent on a virion surface protein encoded by the A28L gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-9-6

The product of the vaccinia virus L5R gene is a fourth membrane protein encoded by all poxviruses that is required for cell entry and cell-cell fusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1743-422X-9-6

21 January 2018

Identifiers

DOI

10.1186/1743-422X-9-6

1 reference

10 August 2017

1 reference

10 August 2017

1 reference